The primary job of a CEO isn’t just the face of the

New Post Public Reply Private Reply Replies (1) Message Board
jeff67 Hulk767 #95324
413
The primary job of a CEO isn’t just the face of the company. It’s defining the strategy and setting the direction of the company. It’s evaluating “events on the ground” and interpreting them as either “stay the course” or “change course”. Sound simple ? Well NP did just this last year in the Spring. When Covid hit , he could have decided to stick to “ our bread and butter” of HIV and cancer or go all in on Covid. Then came Covid..This was a huge decision which may make him a hero or a goat. The learning curve was big. Will the FDA change how they do business to fight a pandemic. Will trials be sped up to get drugs to market . If we get approved will we have a decent amount of inventory? Do we have the money or do we need to borrow to do all of this?
So he jumped in head first. The early results are poor to mixed . We found out the bureaucracy of the government health care agencies were stuck in the mud and were not very flexible in altering their current procedures. Bad drugs got EUAs , good drugs from small companies were back burnered because of the risk averse nature of the fda. Go with big Pharma!. We also have been 2 steps behind in the virus in other nations. But we did get a solid baseline from cd10 to structure our LH phase 2 trial. Preliminary results are strong with the detail and remainder of the analysis due out very soon. The Brazil trial kicks off this week . And the delta variant is on the rise in countries who have poor vaccination track records which means another wave may be coming.
So the jury is out but it must play out to the end .Lincoln could have thrown in the towel to Jefferson Davis by the end of 1862 because the South was pummeling the North. But Lincoln hung in there, ended up deploying great generals including US Grant, and the rest is history.
A strong phase 3 preliminary result down the line may bring in parallel, an EUA for LH. The pressure is mounting on this crisis and will get airplay. Brazilis still a mess and we have a good idea how the trial will come out now as we have tuned the trials for covid.
But if it all fails , NP will have failed because the shift in strategy he implemented would have failed
So this was a Long story but the short of it is, the most important role of a CEO is the strategy and it’s success or failure. The face of the company is not the measuring stick..

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

TJC Secures $2.1 Billion for Continuation Fund Expansion

Updated Category News Views 87

TJC LP announced the closure of a whopping $2.1 billion continuation fund back in mid-2024, setting the stage for some serious shifts in private equity. This ain’t just pocket change; it’s a strategic move aimed at extending The Resolute Fund III, L.P., while also pulling in assets co-owned with Resolute IV, L.P. TJC's Big Play: Five Companies and Counting The...

Continue Reading
Lendmark Financial Services Secures $400 Million in Notes

Updated Category News Views 513

Lendmark Financial Services Secures $400 Million in Senior Notes Lendmark Financial Services, LLC has made a significant move by pricing an impressive $400 million of unsecured senior notes due in 2030. This private offering is expected to strengthen the company's financial position and further its capabilities in providing consumer loans. The notes, which will carry an...

Continue Reading
Village Farms Takes Center Stage at DEA Hearing on Cannabis

Updated Category News Views 44

Village Farms Leading the Charge at DEA Hearing Village Farms International, Inc. (NASDAQ: VFF), a pioneer in sustainable agriculture, is making headlines as the only cannabis operator invited to testify at the Drug Enforcement Administration's (DEA) Administrative Law Judge (ALJ) hearing focused on the potential rescheduling of cannabis. This event highlights Village...

Continue Reading
Celebrating Kindness: Kindsight's Impactful Fundraising Awards

Updated Category News Views 212

Celebrating Excellence in Fundraising at the Kindness Awards Kindsight, a prominent player in fundraising intelligence software, has taken a significant step forward by honoring outstanding achievements through its inaugural Kindness Awards. This prestigious event took place during KindCon 2025, where clients and partners gathered to celebrate innovation and success in...

Continue Reading
EssilorLuxottica Faces Mixed Results in Q3 Revenue Performance

Updated Category News Views 59

EssilorLuxottica’s Q3 Revenue Challenges Shares of EssilorLuxottica faced a downturn recently following the third quarter revenue report, which fell short of market expectations. Investors reacted as the eyewear giant posted revenues of €6.44 billion, indicating a 2% miss compared to projections. Despite a solid constant exchange rate growth of 4%, it did not meet...

Continue Reading